Computed tomography (CT) provides information about patient contours and localization of both tumor and sensitive normal structures, and is expected to significantly improve the accuracy of calculated dose distributions in treatment planning. Therefore, most whole body CT scanner systems commonly include software for dose distribution calculation in treatment planning. But it is usually impossible to mark treatment parameters, such as the beam directions, corners of radiation fields and the center of tumor, on the skin surface of a patient.
We have developed a new optical positioning apparatus (OPA) and attached it to a commercial CT scanner (Pfizer/AS & E model 450). We have also developed an operation software for consistently carrying out treatment planning using CT images and for marking the determined treatment parameters on the patient skin surface. It was named the patient beam positioning system (BPS).
The OPA is an optical apparatus which can irradiate a laser spot beam for any direction on the patient's skin surface. Four parameters are needed to control the OPA. The source position of the light spot beam can be rotated around the central axis of the gantry on the transaxial plane (α rotation) and it can be translated in the direction of the central axis (
z translation). The light spot beam can be aligned in any direction by two axis rotation of tilt angles on the transaxial plane (β rotation) and on the longitudinal plane (γ rotation). α of the rotation angle is within ±100° and
z of the translation length is 0-300mm. β of the tilt angle on the transaxial plane is within ±120° and γ of the tilt angle on the longitudinal plane is within ±45°.
The OPA is connected with the computer system (DEC PDP LSI-11) of the CT. By observing CT images on the CRT screen of the CT console, target volume is defined, and field size and beam direction of each beam are decided enclosing the target volume by interactive operation. The operation software is in three parts. The first is the program to manipulate treatment parameters superimposed on a displayed CT image. The second is the program to calculate dose distributions using the determined parameters. For this purpose, we use Pfizer's CTRT program based on the TP-11 treatment planning system. The third is the program to control the OPA according to parameters determined in the former program.
In this report on the first version of the software, the center of tumor, and the central beam axes and the four corners of the rectangular fields are marked on the skin by the OPA. The spot size of laser beam is about 6mm and total accuracy of hardware for marking on the skin surface is within ±2mm. Clinical work using the BPS has been started.
抄録全体を表示